Cargando…
Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information
Autores principales: | Talamonti, Marina, Galluzzo, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475382/ https://www.ncbi.nlm.nih.gov/pubmed/32953771 http://dx.doi.org/10.21037/atm.2020.04.05 |
Ejemplares similares
-
HLA‐C*06:02 allele can influence clinical efficacy of certolizumab pegol?
por: Dattola, Annunziata, et al.
Publicado: (2021) -
OA02.06. Importance of drug authentication and standardization as per API with the example of Alpinia species
por: Nini, KG, et al.
Publicado: (2013) -
A Single SNP Surrogate for Genotyping HLA-C*06:02 in Diverse Populations
por: Stuart, Philip E., et al.
Publicado: (2014) -
HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
por: Nakkam, Nontaya, et al.
Publicado: (2018) -
Importance of Pharmacogenetics and Drug–Drug Interactions in a Kidney Transplanted Patient
por: Concha, Julia, et al.
Publicado: (2023)